The number of patients at King’s Lynn’s Queen Elizabeth Hospital who have tested positive for COVID-19 has risen from 40 on Tuesday to 71 to date and 15 of these patients have been discharged.
The figure has been revealed as the hospital announced one patient, who is currently receiving treatment for COVID-19, has joined a research trial into a range of potential treatments in the fight against the virus.
The patient is the first from the hospital to be recruited to the national Recovery Trial, which will include a range of different treatments to establish evidence about which drugs have proven benefits against COVID-19.
The focus of the trial is drugs commonly used to treat HIV (Lopinavir-Ritonavir), inflammation steroids (low-dose Dexamethasone) and anti-malarial drugs (Hydroxychloroquine).
Dr Antonia Hardcastle, research lead at the hospital, said: “This is a really important trial, and I am glad we are in the position to offer these novel therapies to our patients in West Norfolk.”
Zoe Coton, research nurse, said: “On behalf of the team, we would like to thank everyone for their support in setting up and recruiting our first patient to this ground-breaking trial.”